Renee N. Kreeger, MD, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio; Chandra Ramamoorthy, MBBS, FFA (UK),
Stanford University Medical Center/Lucile Packard Children’s Hospital, Palo Alto, California; Susan C. Nicolson, MD, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania; Warwick A. Ames, MBBS, FRCA, Duke University Medical Center, Durham, North Carolina; et al.
Summary of presentation as presented by Renee N. Kreeger, MD, at the Society of Thoracic Surgeons meeting in Ft. Lauderdale, Florida, January 30, 2012.
Cerebral hypoxia-ischemia remains a not infrequent complication in children with congenital heart disease (CHD) before, during and after cardiothoracic interventions. Near-infrared spectroscopy (NIRS), a non-invasive optical technology, can be utilized at the bedside to monitor brain oxygenation and detect hypoxiaischemia. The purpose of this multi-center study was to calibrate and validate a novel NIRS device for CHD.